Yet another front has opened in Apple’s ongoing legal battle with a small medical software company over allegations that the tech giant used its patents in a blood oxygen sensor found in the newer version of the Apple Watch. The U.S. Patent Trial and Appeal Board has agreed to review some of the patents in question, marking a significant development in the ongoing dispute. For further details, you can read the article on Law360 here.